Dual HER2-blockade with pertuzumab and trastuzumab in HER2-positive early breast cancer: a subanalysis of data from the randomized phase III GeparSepto trial
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2017
|
| In: |
Annals of oncology
Year: 2016, Volume: 28, Issue: 3, Pages: 497-504 |
| ISSN: | 1569-8041 |
| DOI: | 10.1093/annonc/mdw610 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1093/annonc/mdw610 |
| Author Notes: | S. Loibl, C. Jackisch, A. Schneeweiss, S. Schmatloch, B. Aktas,C. Denkert, H. Wiebringhaus, S. Kümmel, M. Warm, S. Paepke, M. Just, C. Hanusch, J. Hackmann, J.-U. Blohmer, M. Clemens, S. Dan Costa, B. Gerber, K. Engels, V. Nekljudova, G. von Minckwitz, M. Untch on behalf of the investigators of the German Breast Group (GBG) and the Arbeitsgemeinschaft Gynäkologische Onkologie - Breast (AGO-B) study groups |
| Item Description: | Published online: 10 November 2016 Gesehen am 12.04.2018 |
|---|---|
| Physical Description: | Online Resource |
| ISSN: | 1569-8041 |
| DOI: | 10.1093/annonc/mdw610 |